Sign in
4

Changes in Ownership

Lantern Pharma Inc. Filed Acc 0001493152-25-014614

Options or other derivatives

  • Director acquired 12,335 shares (grant or award)
  • Director returned 12,335 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

KEYSER D JEFFREY · Director

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2020-06-15 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −9,135 0 D
2020-06-15 Grant or award : show line 2 in the form Stock Option (Right to Buy) +9,135 9,135 D
2021-11-04 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −3,200 0 D
2021-11-04 Grant or award : show line 4 in the form Stock Option (Right to Buy) +3,200 3,200 D
Loading xslF345X05/ownership.xml…